1. Home
  2. UMH vs QURE Comparison

UMH vs QURE Comparison

Compare UMH & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UMH

UMH Properties Inc.

HOLD

Current Price

$15.31

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$26.62

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UMH
QURE
Founded
1968
1998
Country
United States
Netherlands
Employees
540
248
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
UMH
QURE
Price
$15.31
$26.62
Analyst Decision
Strong Buy
Buy
Analyst Count
4
14
Target Price
$17.75
$45.00
AVG Volume (30 Days)
683.9K
1.8M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
5.84%
N/A
EPS Growth
N/A
29.67
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$5.51
$126.12
Revenue Next Year
$2.51
$200.43
P/E Ratio
$203.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.93
$8.73
52 Week High
$17.44
$71.50

Technical Indicators

Market Signals
Indicator
UMH
QURE
Relative Strength Index (RSI) 50.74 55.52
Support Level $14.74 $23.06
Resistance Level $15.56 $29.03
Average True Range (ATR) 0.30 1.84
MACD -0.03 -0.09
Stochastic Oscillator 57.58 38.29

Price Performance

Historical Comparison
UMH
QURE

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries, is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents. The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, it sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for its sites and homes, where the company is the lessor.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: